XFOR SCHEDULE 13G/A: SEC filing
Coastlands Capital LP
Filed with the SEC on · accession 0001104659-26-127412
XFOR filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 13, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -1.6% by the first close after the filing.
Summary of the filing
Coastlands Capital LP filed an amended Schedule 13G reporting beneficial ownership of 10,719,139 shares (9.99%) of X4 Pharmaceuticals common stock, including shares underlying pre-funded warrants, reflecting recent transactions.
Key details
How XFOR stock reacted
Close before
$3.17
Nov 12, 2026
First close after
-1.58%
$3.12
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for XFOR, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for XFOR?
Click hereFrequently asked questions
What did XFOR file with the SEC on Nov 13, 2026?
XFOR filed a SCHEDULE 13G/A (SEC filing). Coastlands Capital LP filed an amended Schedule 13G reporting beneficial ownership of 10,719,139 shares (9.99%) of X4 Pharmaceuticals common stock, including shares underlying pre-funded warrants, reflecting recent transactions.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did XFOR stock react to this filing?
XFOR closed at $3.17 before the filing and $3.12 on Nov 13, 2026 (-1.58%).
Other XFOR SEC filings
- 10-Q · Material agreementNov 4, 2026
- 8-K · SEC filingOct 29, 2026
- 8-K · Material agreementOct 8, 2026
- SCHEDULE 13G/A · SEC filingOct 7, 2026
- 8-K · SEC filingSep 9, 2026
- 8-K · Fda approvalSep 8, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · Board changeJul 1, 2026
Get alerts when XFOR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days